當前位置：   首頁 > 需求大廳

 >  特色服務 

 >  信息服務 

1.論批生產記錄設計的有效性對產品質量追溯的影響——以公司內膠囊及片劑產品批生產記錄為例 2.Federal Health bulletin 4（1961）12:189 需要這個文獻 3.Morton RF, et al. Studies on the absorption, diffusion, and excretion of cycloserine. Antibiot Annu 1955-56; 3: 169-72. 4.Acta Gastroenterol Belg.1969,32（10）：771-777 A NEW ANTISPASMODIC DRUG IN THE TREATMENT OF BILIARY AND INTESTINAL DISCASCS:A CLINICAL TEST. 5.a process for preparing (S)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one https://priorart.ip.com/IPCOM/000238343   [更多]

簡介：藥智人才是最專業的醫藥產業招聘平臺，與許多醫藥行業的知名企業都有合作，職位種類豐富，崗位更專業~ 賺取賞金規則（活動時間：5月13日-5月17日）： 1.免費注冊/登錄藥智人才（https://job.yaozh.com/），上傳簡歷： 簡歷完善度≥80 可獲得50元賞金； 2.簡歷完成后，并截圖藥智人才簡歷板塊的完善度提交審核，并且備注藥智人才的用戶名/注冊手機信息； 3.審核通過后，賞金會在3個工作日內審核并發放，如提交后有刪除簡歷的行為，視為作弊處理，對應賞金將會被凍結不予提現。 4.特別福利：簡歷完善后既有機會直接內推給名企噢~ 溫馨提示： 1.如果疑問可以聯系客服QQ：3413833812 2.一經發現求職者在上傳簡歷期間有作弊等行為，藥智人才將取消其賞金并凍結該筆提現。 3.在法律允許的范圍內，本活動一切解釋權歸藥智人才 下期活動預告 活動日期：5月20-5月24日 賞金金額：更多賺取賞金細則5月20日揭曉噢~   [更多]

1.Nihon Yakurigaku Zasshi. 2013 Jul;142(1):39-46. doi: 10.1254/fpj.142.39. Pharmacological and clinical properties of AIMIX combination tablets LD&HD, fixed-dose combination of irbesartan and amlodipine besilate. 2.Am J Cardiovasc Drugs. 2013 Apr;13(2):141-50. doi: 10.1007/s40256-013-0014-7. Irbesartan/amlodipine: a review of its use in adult patients with essential hypertension not adequately controlled with monotherapy. 3.Clin Ther. 2012 Aug;34(8):1705-19. doi: 10.1016/j.clinthera.2012.06.026. Epub 2012 Jul 30. I-COMBINE study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with amlodipine monotherapy in hypertensive patients uncontrolled with amlodipine 5 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study. 4.Clin Ther. 2012 Aug;34(8):1720-34.e3. doi: 10.1016/j.clinthera.2012.07.001. Epub 2012 Jul 30. I-ADD study: assessment of efficacy and safety profile of irbesartan/amlodipine fixed-dose combination therapy compared with irbesartan monotherapy in hypertensive patients uncontrolled with irbesartan 150 mg monotherapy: a multicenter, phase III, prospective, randomized, open-label with blinded-end point evaluation study. 5.Am J Cardiovasc Drugs. 2013 Apr;13(2):141-50. doi: 10.1007/s40256-013-0014-7. Irbesartan/amlodipine: a review of its use in adult patients with essential hypertension not adequately controlled with monotherapy. 6J Cardiol. 2019 Mar 20. pii: S0914-5087(19)30053-X. doi: 10.1016/j.jjcc.2019.03.001. [Epub ahead of print] Arginine vasopressin antagonism in heart failure: Current status and possible new directions. Goldsmith SR1. 7.Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability 8.Expert Rev Neurother. 2017 Jan;17(1):59-75. Epub 2016 Oct 20. Modulation of GLP-1 signaling as a novel therapeutic approach in the treatment of Alzheimer's disease pathology. Tramutola A1, Arena A1,   [更多]

1.丙氨酰谷氨酰胺及其注射液的研究開發 2.A prospective multicentre study on the treatment of cardiovascular risk factors and claudication symptoms in patients with peripheral artery disease (the IDOMENEO study). Cimminiello C, Arpaia G, Polo Friz H, Boracchi P, Marano G, Spezzigu G, Visonà A. Vasa. 2015 Sep;44(5):371-9. doi: 10.1024/0301-1526/a000456. 3.2013 International Conference on Materials Engineering, ICMEN 2013 4.Orientation of substitution in the aromatic series. XVIII. Sulfonation of phenol by chlorosulfonic acid in solvents 5.Mechanism of reaction of chlorosulfonic acid with some aromatic compounds 6.Arzneimittelforschung. 1982;32(3):248-51. In vitro--in vivo correlation, a time scaling problem? Basic considerations on in vitro dissolution testing. 7.Oral treatment with the Crataegus special extract WS 1442 inhibits cardiac hypertrophy in rats with DOCA-salt or aortic banding induced hypertension   [更多]

1.Nakashima M, Morita J, Aizawa K. Pharamacokinetics and safety of tebipenem pivoxil fine granules, an oral carbapenem antibiotic, in healthy male volunteers. Jpn J Chemother. 2009;57(S–1):90–94 2.Baba S, Yamanaka N, Suzuki K, et al. Clinical efficacy, safety and PK-PD analysis of tebipenem pivoxil in a phase II clinical trial in otolaryngological infections. Jpn J Antibiot. 2009;62:155–177 3.Sunakawa K. Pharmacological properties and clinical performance of the novel oral carbapenem antimicrobial drug, “Tebipenem pivoxil” (Orapenem fine granules 10% for pediatric use). Jpn J Chemother. 2009;57:279–294 4.Yamanaka N, Furukawa M, Furuya, et al. Clinical efficacy of tebipenem pivoxil (ME1211), a novel oral carbapenem, in otolaryngological infections, a Phase II clinical trial (1). 45th Intersci Conf Antimicrob Agents Chemother (ICAAC) 2005; Abstract L-577 5.Iwata S, Ouchi K, Iwata N, et al. An open clinical study of tebipenem pivoxil in children with bacterial pneumonia. Jpn J Chemother. 2009;57(S–1):137–150   [更多]

1、Atropine and scopolamine premedication – Pharmacological aspects and present use in Finland 2、Identification and purity test of heparin by NMR - a summary of two years' experience at the Medical Products Agency By: McEwen I; Amini A; Olofsson I M 3、Atti della Accademia Nazionale dei Lincei, Classe di Scienze Fisiche, Matematiche e Naturali, Rendiconti 4、49-12 Metabolic Fate of Triethylenetetramine dihydrochloride (Trientine hydrochloride, TJA-250) 1. Absorption, Distribution and Excretion in Rats after Single … S Takeda, E Ono, Y Matsuzaki… - Oyo Yakuri …, 1995 - [Sendai, Japan: Oyo Yakuri … 5、49-13 Metabolic Fate of Triethylenetetramine dihydrochloride (Trientine hydrochloride, TJA-250) 2. Metabolism study in Rats Using 14C-TJA 250 S Takeda, E Ono, Y Wakui… - Oyo Yakuri …, 1995 - [Sendai, Japan: Oyo Yakuri …   [更多]

公司需求幾篇藥品文獻資料。臨床應用數據。具體產品私信我找到一篇50元   [更多]

光子修復凝膠一類醫療器械備案全套資料   [更多]

1. （7）G G, Shapiro ，Effects of albuterol and procaterol on exercise-induced asthma，Annals of allergy 65(4):273-6 . November 1990. 2. G G, Shapiro ，Effects of albuterol and procaterol on exercise-induced asthma，Annals of allergy 65(4):273-6 . November 1990. 3. 1.NAFLD in Asia—as common and important as in the West 4. Fundamentals of the chemotherapy of trichomoniasis and amebiasis with ornidazole 5. Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism 6. [1] Cheesman EH, Blanchette MA, Ganey MV, Maheu LI, Miller SJ, Watson AD. Technetium-99m ECD: ester-derivatizeddiamine-dithiolTc complexesforimaging brain perfusion [Abstract].J Nucl Med, 1988, 29:788. 7. [2] Demonceau G, Leveille J, De Roo M et al. Comparison of Tc-99m-ECD and Tc-99m-HMPAO: First human resulte[Abstract]. J Nucl Med, 1988, 29(5): 747. 8. standards of medical care in diabetic peripheral neuropathy 9. 2017年中藥飲片行業發展藍皮書   [更多]

1.Studies on the synergism of sulbactam and beta-lactam antibiotics under in vitro conditions and in healthy volunteers after intravenous administration. Antibacterial activity in vitro, compatibility and pharmacokinetics of the drugs in combination 2.Review of activity and therapeutic use of sulbactam with ampicillin: D. M. Campoli-Richards, R. N. Brogden, Drugs 33, 577-609 (1987). 3.中藥大品種科技競爭力報告 2018版 4.Comparisons of synthetic 1-18 ACTH (Organon 2001) and 1-39 ACTH of animal origin in human subjects. Behav Neuropsychiatry. 1976 Apr-1977 Mar;8(1-12):3-5. 5. Chem.Abstr.1961# 24578 6. Doklady TSKhA1960vol. 52p. 443,444-450 7. 4.Perez-Ruiz F, Hingorani V, Welp J, et al. Efficacy and safety of a range of doses of RDEA594, a novel uricosuric agent, as a single agent in hyperuricemic gout patients: multicenter, randomized, double-blind, placebo-controlled, phase 2 experience [J]. Ann Rheum Dis, 2010, 69(Suppl 3): 121 8. 化學療法の領域（） 名稱：Stability of cefoperazone By: Takakura, Isamu; Kokei, Tetsuo; Watanabe, Keiko Source: Kagaku Ryoho no Ryoiki（化學療法の領域）, Volume: 6, Issue: 2, Pages: 324-34, Journal, 1990, CODEN: KRRYEI, ISSN: 0913-2384 Company/Organization: Toyama Kagaku Kogyo K. K., Japan   [更多]